Want to create an interactive transcript for this episode?
Podcast: Fitt Insider
Episode: Hims vs Novo Nordisk, Running vs at-home fitness, Women's performance research scores $50M
Description: February 6, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Hims launches compounded GLP-1 pill starting at $49/month as needle-free alternative, but Novo Nordisk threatens legal action over what it calls illegal compounding Women's Health, Sports, and Performance Medical Institute launches with $50M+ to fund injury prevention research for female athletes Peloton reports Q2 revenue of $656.5M missing expectations with paid subscribers down 7% year-over-year, while Brooks reports revenue up 16% marking ninth straight year of growth More from Fitt: Fitt Insider breaks down...